Gland Pharma Limited IPO
Gland Pharma Limited IPO is listed on BSE and NSE, priced at ₹1490–₹1500 per share. The stock debuted at ₹1710, delivering a listing gain of 14.0%. The IPO had a lot size of ₹10 shares and a minimum investment of ₹15,000.
Gland Pharma Limited IPO
- IPO Dates
- Nov 9, 2020 – Nov 11, 2020
- Price band
- ₹1490 - 1500 per equity share
- Minimum Investment
- ₹15,000
- Issue size
- 43,196,968 Eq Shares of ₹1 (aggregating up to ₹6,479.55 Cr) Fresh Issue:8,333,333 Eq Shares of ₹1 (aggregating up to ₹1,250.00 Cr) Offer for Sale: 34,863,635 Eq Shares of ₹1 (aggregating up to ₹5,229.55 Cr)
- Lot size
- 10
- Allotment Date
- Nov 18, 2020
- Listing
- Nov 20, 2020
- Listing At
- BSE, NSE
IPO timeline
-
Nov 9, 2020
Open Date
Completed
-
Nov 11, 2020
Close Date
Completed
-
Nov 18, 2020
Allotment Date
Completed
-
Nov 20, 2020
Listing Date
Completed
Price Summary
- Last closing
- 1,895.00 (26.33%)
- 52 week high
- 2,131.00
- 52 week low
- 1,425.10
- Last update
Gland Pharma Limited IPO Subscription Details
View Subscription DetailsGland Pharma Limited IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Gland Pharma Limited IPO Essentials
Gland Pharma Limited IPO Details
Gland Pharma Limited IPO is priced at ₹1490 - 1500 per share with a total issue size of 43,196,968 Eq Shares of ₹1 (aggregating up to ₹6,479.55 Cr) Fresh Issue:8,333,333 Eq Shares of ₹1 (aggregating up to ₹1,250.00 Cr) Offer for Sale: 34,863,635 Eq Shares of ₹1 (aggregating up to ₹5,229.55 Cr). The IPO has a lot size of 10 shares and is listed on BSE and NSE.
- Issue price
- ₹1490 - 1500 per equity share
- Lot size
- 10 shares
- Face value
- ₹1 Per Equity Share
- Issue size
- 43,196,968 Eq Shares of ₹1 (aggregating up to ₹6,479.55 Cr)
Fresh Issue:8,333,333 Eq Shares of ₹1 (aggregating up to ₹1,250.00 Cr)
Offer for Sale: 34,863,635 Eq Shares of ₹1 (aggregating up to ₹5,229.55 Cr) - Listing at
- BSE, NSE
- List price
- 1710.0
- Listing date
- Registrar
- Link Intime India Private Ltd
- Lead manager
-
Citigroup Global Markets India Private Limited, Haitong Securities India Private Limited, Kotak Mahindra Capital Company Limited, Nomura Financial Advisory And Securities (India) Pvt Ltd
Gland Pharma Limited IPO Analytics
Gland Pharma Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Gland Pharma Limited IPO Subscription Status
Gland Pharma Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB |
NII
|
Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 8,639,394 |
6,479,546
|
15,118,939 | 27,350,957 |
|
Day 1
09-11-20 05:00 PM
|
0.00 x |
0.01x
|
0.08 x | 0.05 x |
|
Day 2
10-11-20 05:00 PM
|
0.48 x |
0.03x
|
0.15 x | 0.22 x |
|
Day 3
11-11-20 06:00 PM
|
6.40 x |
0.51x
|
0.24 x | 2.06 x |
Gland Pharma Limited Valuations
Earnings
- EPS (Post IPO)
- N/A
Returns
- RoNW
- N/A
Gland Pharma Limited Financials( In Crs.)
| 31-Mar-20 | 31-Mar-19 | 31-Mar-18 | |
|---|---|---|---|
| Assets | 4,086.03 | 3,523.54 | 2.929.46 |
| Revenue | 2,772.40 | 2,129.76 | 1,671.68 |
| Profit After Tax | 772.85 | 451.85 | 321.05 |
Gland Pharma Limited Company & Offer Insights
About Gland Pharma Limited
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets.
They operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. This presence across the value chain has helped them witness exponential growth.
They are promoted by Shanghai Fosun Pharma, a global pharmaceutical major.
Gland Pharma Limited IPO Issue Objectives
- •
- To finance the incremental working capital requirements of our Company
- •
- To meet funding requirements for capital expenditure requirements
- •
- To meet the general corporate purposes
Contact Information
Frequently Asked Questions
Click any question to reveal the answer
Gland Pharma Limited IPO is a book-built IPO worth ₹43,196,968 Eq Shares of ₹1 (aggregating up to ₹6,479.55 Cr) Fresh Issue:8,333,333 Eq Shares of ₹1 (aggregating up to ₹1,250.00 Cr) Offer for Sale: 34,863,635 Eq Shares of ₹1 (aggregating up to ₹5,229.55 Cr). The price band is ₹1490–₹1500 per share. The IPO opens on Nov 9, 2020 and closes on Nov 11, 2020. It will be listed on BSE and NSE. Link Intime India Private Ltd is the registrar.
The price band of Gland Pharma Limited IPO is ₹1490 to ₹1500 per share.
The lot size of Gland Pharma Limited IPO is 10 shares.
The minimum investment for Gland Pharma Limited IPO is approximately ₹15,000 based on the upper price band .
Gland Pharma Limited IPO opens on Nov 9, 2020 and closes on Nov 11, 2020.
The allotment date of Gland Pharma Limited IPO is Nov 18, 2020.
Gland Pharma Limited IPO is expected to be listed on Nov 20, 2020, on BSE and NSE .
Gland Pharma Limited IPO listed on Nov 20, 2020. It was issued at ₹1710.0 and is currently around ₹1895.00 as on 14-May-2026 3:30 PM, which is approximately 26.3% versus issue price. The 52-week high is ₹2,131.00.
Based on listing and post-listing performance, Gland Pharma Limited IPO delivered around 26.3% over issue price. Whether it was worth applying depends on your risk profile, allocation, and holding horizon.
To buy Gland Pharma Limited IPO shares after listing, log in to your broker app (such as Zerodha, Angel One, Groww, Upstox, ICICI Direct), search the stock symbol, place a delivery/CNC order, and confirm quantity and price.
To apply for Gland Pharma Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Gland Pharma Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Gland Pharma Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Gland Pharma Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Gland Pharma Limited IPO allotment status on IPO Ji for quick and easy access.